Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

509 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccination potential of B and T epitope-enriched NP and M2 against Influenza A viruses from different clades and hosts.
Tutykhina I, Esmagambetov I, Bagaev A, Pichugin A, Lysenko A, Shcherbinin D, Sedova E, Logunov D, Shmarov M, Ataullakhanov R, Naroditsky B, Gintsburg A. Tutykhina I, et al. Among authors: lysenko a. PLoS One. 2018 Jan 29;13(1):e0191574. doi: 10.1371/journal.pone.0191574. eCollection 2018. PLoS One. 2018. PMID: 29377916 Free PMC article.
Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus.
Shmarov MM, Sedova ES, Verkhovskaya LV, Rudneva IA, Bogacheva EA, Barykova YA, Shcherbinin DN, Lysenko AA, Tutykhina IL, Logunov DY, Smirnov YA, Naroditsky BS, Gintsburg AL. Shmarov MM, et al. Among authors: lysenko aa. Acta Naturae. 2010 Apr;2(1):111-8. Acta Naturae. 2010. PMID: 22649637 Free PMC article.
Non-neutralizing Antibodies Directed at Conservative Influenza Antigens.
Sedova ES, Scherbinin DN, Lysenko AA, Alekseeva SV, Artemova EA, Shmarov MM. Sedova ES, et al. Among authors: lysenko aa. Acta Naturae. 2019 Oct-Dec;11(4):22-32. doi: 10.32607/20758251-2019-11-4-22-32. Acta Naturae. 2019. PMID: 31993232 Free PMC article.
Safety and immunogenicity of GamEvac-Combi, a heterologous VSV- and Ad5-vectored Ebola vaccine: An open phase I/II trial in healthy adults in Russia.
Dolzhikova IV, Zubkova OV, Tukhvatulin AI, Dzharullaeva AS, Tukhvatulina NM, Shcheblyakov DV, Shmarov MM, Tokarskaya EA, Simakova YV, Egorova DA, Scherbinin DN, Tutykhina IL, Lysenko AA, Kostarnoy AV, Gancheva PG, Ozharovskaya TA, Belugin BV, Kolobukhina LV, Pantyukhov VB, Syromyatnikova SI, Shatokhina IV, Sizikova TV, Rumyantseva IG, Andrus AF, Boyarskaya NV, Voytyuk AN, Babira VF, Volchikhina SV, Kutaev DA, Bel'skih AN, Zhdanov KV, Zakharenko SM, Borisevich SV, Logunov DY, Naroditsky BS, Gintsburg AL. Dolzhikova IV, et al. Among authors: lysenko aa. Hum Vaccin Immunother. 2017 Mar 4;13(3):613-620. doi: 10.1080/21645515.2016.1238535. Epub 2017 Feb 2. Hum Vaccin Immunother. 2017. PMID: 28152326 Free PMC article. Clinical Trial.
[Surgical treatment of a patient with syphilitic aortitis].
Lysenko AV, Belov YV, Charchyan ER, Polyakov RS, Magomedova GF. Lysenko AV, et al. Khirurgiia (Mosk). 2024;(5):123-128. doi: 10.17116/hirurgia2024051123. Khirurgiia (Mosk). 2024. PMID: 38785248 Russian.
509 results